UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...

A former nurse with multiple health conditions says she "owes her life" to support groups she says helped her through the ...

“Lung disease is the third biggest cause of death in the UK, and every year up to 30,000 people die from COPD. “Although COPD is a relatively common disease, public awareness is limite ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Individuals in the lowest quintile of birth weight appear to have an increased risk for subsequent chronic obstructive ...

Scotland has the highest rate of drugs deaths in Europe, with fatalities rising by 12% in a year to 1,172 drug-related deaths ...

highlighting the importance of early-life factors in COPD development. The study utilized the UK Biobank, analyzing over 250,000 participants, and adjusted for demographic, health, and lifestyle ...

Speaking over the HMPV virus cases, the Chairman of PSRI Institute of Pulmonary, Critical Care & Sleep Medicine, Dr Gopi ...

MSD has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for sotatercept, marketed as Winrevair, to treat pulmonary arterial hypertension (PAH) in the adult ...

Windward Bio's lead candidate, WIN378, which has been in-licensed from Kelun-Biotech and Harbour BioMed, is a potential best-in-class, long-acting monoclonal antibody targeting the ligand of thymic ...

It can make conditions such as chronic obstructive pulmonary disease (COPD ... "So overall, I don't think there is currently ...

Skint households up and down the country can now apply for grants worth up to £500 to help with debt as the Cost of Living ...